Phase I trial, Quotient code: QSC301137, Sponsor code: LMNL6511C1001

Phase 1

• Conditions: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.; Not Applicable

• Registration Number: ISRCTN46791858
• Lead Sponsor: iminal BioSciences (United Kingdom)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-01
• Last Update Posted: 19 December 2023
• Study Completion: 2024-07-23

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Exclusion Criteria

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Secondary Outcome Measures

Name	Time	Method
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.